rxstatShortages › Ibuprofen

Ibuprofen shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ibuprofen products are in shortage in Canada (2 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 3, 2026.
Products affected
2 of 14
In shortage since
May 12, 2021
Est. full return
Jul 3, 2026
Reports on file
40
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · since Jun 23, 2026, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES
400MG · CAPSULE · APOTEX INC
DIN 02376601 · since May 12, 2021, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-PROFEN
600MG · TABLET · TEVA CANADA LIMITED
DIN 00629359
Resolved
APO-IBUPROFEN
400MG · TABLET · APOTEX INC
DIN 00506052 · ended Apr 4, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Mar 28, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
200MG · TABLET · APOTEX INC
DIN 00441643 · ended Mar 28, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Nov 30, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Apr 20, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
400MG · TABLET · APOTEX INC
DIN 00506052 · ended Feb 8, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
200MG · TABLET · APOTEX INC
DIN 00441643 · ended May 13, 2022 · Disruption of the manufacture of the drug.
Discontinued
PMS-IBUPROFEN
600MG · TABLET · PHARMASCIENCE INC
DIN 00839264
Discontinued
PMS-IBUPROFEN
600MG · TABLET · PHARMASCIENCE INC
DIN 00839264

Showing 12 of 40 reports. All reports are on file with Health Canada.

What's happening

Ibuprofen is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ibuprofen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).

Recent changes

Common questions

When will Ibuprofen be back in stock in Canada?

The latest manufacturer estimate is Jul 3, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ibuprofen in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiinflammatory/antirheumatic prod.,non-steroids)

All antiinflammatory/antirheumatic prod.,non-steroids shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.